State of Wyoming’s AstraZeneca AZN Stock Holding History

State of Wyoming’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	–	–	1578
2022 Q3	$0	Hold	1	–	–	﹤0.01%	1546
2022 Q2	$0	Sell	1 -37	-97%	-$4.86K	﹤0.01%	1867
2022 Q1	$5K	Sell	38 -214	-85%	-$25.7K	﹤0.01%	1656
2021 Q4	$29K	Buy	252 +251	+25,100%	+$29.5K	0.01%	1354
2021 Q3	$0	Buy	+1	New	+$116	﹤0.01%	1222

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State of Wyoming's AZN Position: Q4 2022 in Review

State of Wyoming sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 1 share.

State of Wyoming first reported a position in AZN in Q3 2021 and held it in 5 quarters. The position peaked at $29K in Q4 2021. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

State of Wyoming reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
State of Wyoming sold 1 AstraZeneca share in Q4 2022.
State of Wyoming first reported a position in AstraZeneca in Q3 2021 and held it in 5 quarters.
State of Wyoming's AstraZeneca position peaked at $29K in Q4 2021.
1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on State of Wyoming's 13F filing for Q4 2022, filed 15 Feb 2023.